These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 39029875)

  • 1. Rescue with obinutuzumab and daratumumab as combined B cell/plasma cell targeting approach in severe posttransplant focal segmental glomerulosclerosis recurrence.
    Randone P; Sanna E; Dolla C; Gallo E; Mingozzi S; Tarragoni R; Torazza MC; Niarchos A; Mella A; Manzione AM; Barreca A; Deambrosis I; Giraudi R; Biancone L
    Am J Transplant; 2024 Jul; ():. PubMed ID: 39029875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports.
    Fencl F; Simková E; Vondrák K; Janda J; Chadimová M; Stejskal J; Seeman T
    Transplant Proc; 2007 Dec; 39(10):3488-90. PubMed ID: 18089416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of combined rituximab and daratumumab treatment in posttransplant recurrent focal segmental glomerulosclerosis.
    Angeletti A; Bin S; Magnasco A; Bruschi M; Cravedi P; Ghiggeri GM
    Am J Transplant; 2024 Apr; 24(4):688-692. PubMed ID: 38101474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of recurrent focal segmental glomerulosclerosis with a low dose rituximab in a kidney transplant recipient.
    Cho JH; Lee JH; Park GY; Lim JH; Kim JS; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
    Ren Fail; 2014 May; 36(4):623-6. PubMed ID: 24502587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different effects of rituximab on a native kidney and a post-transplant kidney with recurrence of focal segmental glomerulosclerosis.
    Ino A; Kaori S; Takei T; Nitta K
    CEN Case Rep; 2020 Aug; 9(3):195-199. PubMed ID: 31997159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful Treatment of Focal Segmental Glomerulosclerosis Recurrence in a Second Kidney Transplant Patient: A Case Report.
    Argiolas D; Carta E; Mascia G; Michittu MB; Piredda GB
    Transplant Proc; 2019; 51(1):223-225. PubMed ID: 30580884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
    Rodríguez-Ferrero M; Ampuero J; Anaya F
    Transplant Proc; 2009; 41(6):2406-8. PubMed ID: 19715934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoadsorption for Recurrent Primary Focal Segmental Glomerulosclerosis on Kidney Allografts: A Single-Center Experience and Literature Review.
    Naciri Bennani H; Bonzi JY; Noble J; Terrec F; Motte L; Imerzoukene F; Bugnazet M; Giovannini D; Janbon B; Malvezzi P; Rostaing L; Jouve T
    Blood Purif; 2020; 49(3):322-333. PubMed ID: 31913143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of recurrent focal segmental glomerulosclerosis in pediatric kidney transplant recipients: effect of rituximab.
    Sethna C; Benchimol C; Hotchkiss H; Frank R; Infante L; Vento S; Trachtman H
    J Transplant; 2011; 2011():389542. PubMed ID: 21577271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmapheresis for the prophylaxis and treatment of recurrent focal segmental glomerulosclerosis following renal transplant.
    Valdivia P; Gonzalez Roncero F; Gentil MA; Jiménez F; Algarra G; Pereira P; Rivera M; Suñer M; Cabello V; Toro J; Mateos J
    Transplant Proc; 2005 Apr; 37(3):1473-4. PubMed ID: 15866644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Success with plasmapheresis treatment for recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients.
    Straatmann C; Kallash M; Killackey M; Iorember F; Aviles D; Bamgbola O; Carson T; Florman S; Vehaskari MV
    Pediatr Transplant; 2014 Feb; 18(1):29-34. PubMed ID: 24266922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal late-onset Pneumocystis pneumonia after rituximab: administration for posttransplantation recurrence of focal segmental glomerulosclerosis--case report.
    Dęborska-Materkowska D; Kozińska-Przybył O; Mikaszewska-Sokolewicz M; Durlik M
    Transplant Proc; 2014 Oct; 46(8):2908-11. PubMed ID: 25380948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation.
    Tsagalis G; Psimenou E; Nakopoulou L; Laggouranis A
    Artif Organs; 2011 Apr; 35(4):420-5. PubMed ID: 20637013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis: early treatment with plasmapheresis and immunoadsorption should be associated with better prognosis.
    Fencl F; Vondrák K; Rosík T; Zieg J; Chadimová M; Háček J; Dušek J; Seeman T
    Minerva Pediatr; 2016 Oct; 68(5):348-54. PubMed ID: 26041001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab or plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis after kidney transplantation: A systematic review and meta-analysis.
    Boonpheng B; Hansrivijit P; Thongprayoon C; Mao SA; Vaitla PK; Bathini T; Choudhury A; Kaewput W; Mao MA; Cheungpasitporn W
    World J Transplant; 2021 Jul; 11(7):303-319. PubMed ID: 34316454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualized scheme of immunoadsorption for the recurrence of idiopathic focal segmental glomerulosclerosis in the graft: a single center experience.
    Lionaki S; Vlachopanos G; Georgalis A; Liapis G; Skalioti C; Zavos G; Boletis JN
    Ren Fail; 2015 Jun; 37(5):777-83. PubMed ID: 25715638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis.
    Yabu JM; Ho B; Scandling JD; Vincenti F
    Am J Transplant; 2008 Jan; 8(1):222-7. PubMed ID: 17979998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of recurrent focal segmental glomerulosclerosis after kidney transplantation associated with variant conversion in the Columbia classification.
    Unagami K; Kawanishi K; Shimizu T; Kanzawa T; Toki D; Okumi M; Omoto K; Horita S; Koike J; Honda K; Nagashima Y; Ishida H; Tanabe K; Nitta K
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():96-100. PubMed ID: 26031598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmapheresis for recurrent posttransplant focal segmental glomerulosclerosis.
    Garcia CD; Bittencourt VB; Tumelero A; Antonello JS; Malheiros D; Garcia VD
    Transplant Proc; 2006; 38(6):1904-5. PubMed ID: 16908318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined rituximab and plasmapheresis or plasma exchange for focal segmental glomerulosclerosis in adult kidney transplant recipients: a meta-analysis.
    Hansrivijit P; Ghahramani N
    Int Urol Nephrol; 2020 Jul; 52(7):1377-1387. PubMed ID: 32306197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.